en

PRODUCT DETAIL

Alyftrek 125 mg/50 mg/10 mg filmom obalené tablety

Code 0611F
MA number EU/1/25/1943/002
Product Form: tbl flm 56(4x14)x125 mg/50 mg/10 mg (blis. PCTFE/PVC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
MAH, country: Vertex Pharmaceuticals (Ireland) Limited, Ireland
Therapeutic Class: 87 - VARIA I
ATC:
R RESPIRATORY SYSTEM
R07 OTHER RESPIRATORY SYSTEM PRODUCTS
R07A OTHER RESPIRATORY SYSTEM PRODUCTS
R07AX Other respiratory system products
R07AX33 Deutivacaftor, tezacaftor and vanzacaftor
Shelf life: 24
Container: blister PCTFE/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 30.06.2025
Validity: 30.06.2030
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 15.07.2025
eu-flag.png sk-flag.png